Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Innospec (IOSP) EBITDA Margin (2016 - 2025)

Innospec (IOSP) has disclosed EBITDA Margin for 16 consecutive years, with 10.27% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 3771.0% to 10.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.28% through Dec 2025, up 681.0% year-over-year, with the annual reading at 7.28% for FY2025, 681.0% up from the prior year.
  • EBITDA Margin hit 10.27% in Q4 2025 for Innospec, up from 1.34% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 10.44% in Q2 2021 to a low of 27.44% in Q4 2024.
  • Historically, EBITDA Margin has averaged 5.66% across 5 years, with a median of 9.08% in 2022.
  • Biggest five-year swings in EBITDA Margin: tumbled -2540bps in 2023 and later soared 3771bps in 2025.
  • Year by year, EBITDA Margin stood at 8.59% in 2021, then rose by 6bps to 9.12% in 2022, then tumbled by -278bps to 16.27% in 2023, then crashed by -69bps to 27.44% in 2024, then skyrocketed by 137bps to 10.27% in 2025.
  • Business Quant data shows EBITDA Margin for IOSP at 10.27% in Q4 2025, 1.34% in Q3 2025, and 7.8% in Q2 2025.